stockrowVaxcyte, Inc. (PCVX) vs Protagonist Therapeutics, Inc. (PTGX)
- Vaxcyte, Inc. PCVX 60.79 −2.00%
- Protagonist Therapeutics, Inc. PTGX 140.29 −3.15%
Vaxcyte, Inc. and Protagonist Therapeutics, Inc. are both Biotechnology companies. Vaxcyte, Inc. and Protagonist Therapeutics, Inc. are of similar size ($9.8B and $9.4B). Vaxcyte, Inc. has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 115×. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs 0.00%) and the higher return on invested capital (61.8% vs −57.3%). Across the 13 metrics below, Protagonist Therapeutics, Inc. leads on 10 and Vaxcyte, Inc. on 3.
Valuation
Profitability
| Metric | PCVX | PTGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 69.20% |
| Operating margin | 0.00% | 20.69% | 0.00% |
| Net margin | 0.00% | 29.40% | 0.00% |
| Free cash flow margin | 0.00% | 46.31% | 0.00% |
| Return on equity | (36.51%) | 10.98% | (53.10%) |
| Return on assets | (33.03%) | 10.34% | (46.06%) |
| Return on invested capital | (57.30%) | 61.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack